These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6135246)

  • 21. Pseudoglucagonoma responsive to somatostatin.
    Lubetzki J; Guillausseau PJ; Binet O; Hautefeuille P; Galian A; Mundler O; Aron-Brunetiere R; Timsit J; Warnet A
    Lancet; 1981 Aug; 2(8241):316-7. PubMed ID: 6114367
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatostatin in gastroenterology. American Gastroenterologic Association, plenary session papers. Chicago, Illinois, May 1987.
    Dig Dis Sci; 1989 Mar; 34(3 Suppl):1S-47S. PubMed ID: 2563964
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic value of somatostatin in gastroenterology. Theoretical basis. Practical trends].
    René E; Reyl F; Bonfils S
    Gastroenterol Clin Biol; 1980 Oct; 4(10):700-8. PubMed ID: 6108277
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-acting somatostatin analog SMS 201-955 (Sandostatin) and its application in clinical gastroenterological practice].
    Meier R; Gyr K
    Schweiz Rundsch Med Prax; 1988 Aug; 77(31-32):813-9. PubMed ID: 2845555
    [No Abstract]   [Full Text] [Related]  

  • 25. [Somatostatin, what are its uses?].
    Saudin F
    Pediatrie; 1987; 42(5):339-49. PubMed ID: 2893334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Somatostatin].
    German SV
    Klin Med (Mosk); 1987 Oct; 65(10):9-15. PubMed ID: 2892967
    [No Abstract]   [Full Text] [Related]  

  • 27. [Somatostatin].
    Tragl KH
    Acta Med Austriaca; 1978; 5(3):80-4. PubMed ID: 377888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin--paracrine and neuromodulator peptide in gut and nervous system.
    Pimstone BL; Berelowitz M
    S Afr Med J; 1978 Jan; 53(1):7-9. PubMed ID: 25488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin--physiological and pathophysiological aspects.
    Schusdziarra V
    Scand J Gastroenterol Suppl; 1983; 82():69-84. PubMed ID: 6138852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The glucagonoma syndrome.
    Bloom SR; Sonksen PH
    J R Soc Med; 1990 Jan; 83(1):60. PubMed ID: 1968103
    [No Abstract]   [Full Text] [Related]  

  • 31. Rebound effect after somatostatin treatment in Verner-Morrison syndrome.
    Bonfils S; René E; Pignal F; Rambaud JC
    Lancet; 1979 Sep; 2(8140):476. PubMed ID: 89540
    [No Abstract]   [Full Text] [Related]  

  • 32. [Somatostatin: its physiological importance and use in the internal disease clinic (a review of the literature)].
    Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(6):93-106. PubMed ID: 341118
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical applications of somatostatin.
    del Pozo E
    Horm Res; 1988; 29(2-3):89-91. PubMed ID: 2900204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin--a regulatory peptide of clinical importance.
    Bethge N; Diel F; Usadel KH
    J Clin Chem Clin Biochem; 1982 Sep; 20(9):603-13. PubMed ID: 6128369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Somatostatin--its practical use in diseases of the digestive tract].
    Paradowski L
    Wiad Lek; 1986 Mar; 39(5):330-4. PubMed ID: 2873690
    [No Abstract]   [Full Text] [Related]  

  • 36. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
    Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
    Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of somatostatin on the digestive tract functions].
    Dwornicki M
    Przegl Lek; 1990; 47(8):593-6. PubMed ID: 1980955
    [No Abstract]   [Full Text] [Related]  

  • 38. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of somatostatin and its analogs in the treatment of surgical disorders.
    Mulvihill S; Pappas TN; Passaro E; Debas HT
    Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus.
    Unger RH; Ipp E; Schusdziarra V; Orci L
    Life Sci; 1977 Jun; 20(12):2081-5. PubMed ID: 329036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.